{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T10:51:08Z","timestamp":1793184668211,"version":"4.5.0"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2025KY634"],"award-info":[{"award-number":["2025KY634"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2023RC128"],"award-info":[{"award-number":["2023RC128"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Zhejiang Provincial Traditional Chinese Medicine Science and Technology Program","award":["2025ZL185"],"award-info":[{"award-number":["2025ZL185"]}]},{"name":"the Basic Scientific Research Funds of Department of Education of Zhejiang Province","award":["KYQN2023010"],"award-info":[{"award-number":["KYQN2023010"]}],"id":[{"id":"https:\/\/ror.org\/05gj07w56","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02355-9","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:14:14Z","timestamp":1767420854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Autophagy-NLRP3 Inflammasome Crosstalk in Microglia: A Therapeutic Target for Multiple Sclerosis"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9789-923X","authenticated-orcid":false,"given":"Jie-Qiong","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5428-9282","authenticated-orcid":false,"given":"Hui-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6636-4347","authenticated-orcid":false,"given":"Ma-Rong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2230-6329","authenticated-orcid":false,"given":"Xiang-Ming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-1285","authenticated-orcid":false,"given":"Kai-Yi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"14","key":"2355_CR1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton, C., R. King, L. Rechtman, W. Kaye, E. Leray, R.A. Marrie, et al. 2020. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Multiple Sclerosis 26 (14): 1816\u201321.","journal-title":"Multiple Sclerosis"},{"issue":"1","key":"2355_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12913-025-12592-1","volume":"25","author":"C Oreja-Guevara","year":"2025","unstructured":"Oreja-Guevara, C., J. E. Meca-Lallana, I. G\u00f3mez-Est\u00e9vez, J. R. Ara, M\u00c1 H P\u00e9rez, and J. G. Gil et al. 2025. Economic burden of secondary progressive multiple sclerosis: DISCOVER study. Bmc Health Services Research 25(1):525.","journal-title":"Bmc Health Services Research"},{"key":"2355_CR3","doi-asserted-by":"publisher","first-page":"175628642211468","DOI":"10.1177\/17562864221146836","volume":"16","author":"A Bayas","year":"2023","unstructured":"Bayas, A., M. Christ, S. Faissner, J. Klehmet, R. Pul, and T. Skripuletz et al. 2023. Disease-modifying therapies for relapsing\/active secondary progressive multiple sclerosis - a review of population-specific evidence from randomized clinical trials. Therapeutic Advances in Neurological Disorders 16:17562864221146836.","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"2","key":"2355_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/15548627.2023.2259281","volume":"20","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy, H.M., M.S. Jabir, A.I. Al-Gareeb, H.M. Saad, G.E. Batiha, and D.J. Klionsky. 2024. The beneficial role of autophagy in multiple sclerosis: Yes or no? Autophagy 20 (2): 259\u201374.","journal-title":"Autophagy"},{"issue":"2","key":"2355_CR5","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2018.11.005","volume":"25","author":"S Voet","year":"2019","unstructured":"Voet, S., M. Prinz, and G. van Loo. 2019. Microglia in central nervous system inflammation and multiple sclerosis pathology. Trends in Molecular Medicine 25(2):112\u2013123.","journal-title":"Trends in Molecular Medicine"},{"issue":"7","key":"2355_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41583-023-00709-6","volume":"24","author":"F Dist\u00e9fano-Gagn\u00e9","year":"2023","unstructured":"Dist\u00e9fano-Gagn\u00e9, F., S. Bitarafan, S. Lacroix, and D. Gosselin. 2023. Roles and regulation of microglia activity in multiple sclerosis: Insights from animal models. Nature Reviews Neuroscience 24(7):397\u2013415.","journal-title":"Nature Reviews Neuroscience"},{"key":"2355_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083889","author":"O Mosora","year":"2025","unstructured":"Mosora, O., S. Maier, D. Manu, L. B\u0103rcu\u021bean, M. Roman, M. Dumitreas\u0103, et al. 2025. Exosomal microRNAs as early transition biomarkers from recurrent-remissive to secondary progressive multiple sclerosis. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms26083889.","journal-title":"International Journal of Molecular Sciences"},{"key":"2355_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9010012","author":"G Jalkh","year":"2020","unstructured":"Jalkh, G., R. Abi Nahed, G. Macaron, and M. Rensel. 2020. Safety of newer disease modifying therapies in multiple sclerosis. Vaccines. https:\/\/doi.org\/10.3390\/vaccines9010012.","journal-title":"Vaccines"},{"key":"2355_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/bs.apcsb.2019.08.007","volume":"119","author":"M Olcum","year":"2020","unstructured":"Olcum, M., B. Tastan, C. Kiser, S. Genc, and K. Genc. 2020. Microglial NLRP3 inflammasome activation in multiple sclerosis. Advances in Protein Chemistry and Structural Biology 119: 247\u2013308.","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"key":"2355_CR10","doi-asserted-by":"publisher","first-page":"1540263","DOI":"10.3389\/fimmu.2025.1540263","volume":"16","author":"C Prado","year":"2025","unstructured":"Prado, C., A. A. Herrada, D. Hevia, L. G. Goiry, and N. Escobedo. 2025. Role of innate immune cells in multiple sclerosis. Frontiers in Immunology 16:1540263.","journal-title":"Frontiers in Immunology"},{"key":"2355_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/genes11020131","author":"RH Pirzada","year":"2020","unstructured":"Pirzada, R.H., N. Javaid, and S. Choi. 2020. The roles of the NLRP3 inflammasome in neurodegenerative and metabolic diseases and in relevant advanced therapeutic interventions. Genes. https:\/\/doi.org\/10.3390\/genes11020131.","journal-title":"Genes"},{"key":"2355_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbrc.2021.08.010","volume":"573","author":"M He","year":"2021","unstructured":"He, M., D. M. Wu, Y. Y. Zhao, Y. Yu, S. H. Deng, and T. Liu et al. 2021. AZD8055 ameliorates experimental autoimmune encephalomyelitis via the mTOR\/ROS\/NLRP3 pathway. Biochemical and Biophysical Research Communications 573:27\u201334.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2355_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.molimm.2017.02.013","volume":"86","author":"J Harris","year":"2017","unstructured":"Harris, J., T. Lang, J. P. W. Thomas, M. B. Sukkar, N. R. Nabar, and J. H. Kehrl. 2017. Autophagy and inflammasomes. Molecular Immunology 86:10\u201315.","journal-title":"Molecular Immunology"},{"issue":"10130","key":"2355_CR14","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A.J., S.E. Baranzini, J. Geurts, B. Hemmer, and O. Ciccarelli. 2018. Multiple sclerosis. Lancet 391 (10130): 1622\u201336.","journal-title":"Lancet"},{"issue":"2","key":"2355_CR15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11481-016-9718-1","volume":"12","author":"S Franck","year":"2017","unstructured":"Franck, S., M. Paterka, J. Birkenstock, F. Zipp, V. Siffrin, and E. Witsch. 2017. Phenotype of antigen unexperienced T(H) cells in the inflamed central nervous system in experimental autoimmune encephalomyelitis. Journal of Neuroimmune Pharmacology : the official Journal of the Society on Neuroimmune Pharmacology 12(2):305\u2013313.","journal-title":"Journal of Neuroimmune Pharmacology : the official Journal of the Society on Neuroimmune Pharmacology"},{"key":"2355_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104789","volume":"96","author":"H Touil","year":"2023","unstructured":"Touil, H., R. Li, L. Zuroff, C.S. Moore, L. Healy, F. Cignarella, et al. 2023. Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis. EBioMedicine 96: 104789.","journal-title":"EBioMedicine"},{"issue":"3","key":"2355_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00011-022-01677-w","volume":"72","author":"J Tian","year":"2023","unstructured":"Tian, J., L. Jiang, Z. Chen, Q. Yuan, C. Liu, and L. He et al. 2023. Tissue-resident immune cells in the pathogenesis of multiple sclerosis. Inflammation Research 72(3):363\u2013372.","journal-title":"Inflammation Research"},{"issue":"4","key":"2355_CR18","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-025-01275-w","volume":"22","author":"W Xu","year":"2025","unstructured":"Xu, W., Y. Huang, and R. Zhou. 2025. NLRP3 inflammasome in neuroinflammation and central nervous system diseases. Cellular & Molecular Immunology 22(4):341\u2013355.","journal-title":"Cellular & Molecular Immunology"},{"issue":"11","key":"2355_CR19","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2174\/011570159X352356241126044933","volume":"23","author":"MT Goulart","year":"2025","unstructured":"Goulart, M. T., D. T. U. Queiroz, and F. M. Ribeiro. 2025. The dual role of microglia in multiple sclerosis and its implications for diagnostics and repair. Current Neuropharmacology 23(11):1351\u20131366.","journal-title":"Current Neuropharmacology"},{"key":"2355_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.msard.2019.01.023","volume":"29","author":"JL Soares","year":"2019","unstructured":"Soares, J. L., E. M. Oliveira, and A. Pontillo. 2019. Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis. Mult Scler Relat Disord 29:26\u201334.","journal-title":"Mult Scler Relat Disord"},{"key":"2355_CR21","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028936","author":"H Lassmann","year":"2018","unstructured":"Lassmann, H. 2018. Multiple sclerosis pathology. Cold Spring Harbor Perspectives in Medicine. https:\/\/doi.org\/10.1101\/cshperspect.a028936.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"6","key":"2355_CR22","doi-asserted-by":"publisher","first-page":"E1194","DOI":"10.1073\/pnas.1714948115","volume":"115","author":"A Par\u00e9","year":"2018","unstructured":"Par\u00e9, A., B. Mailhot, S. A. L\u00e9vesque, C. Juzwik, P. M. Ignatius Arokia Doss, and M. A. L\u00e9cuyer et al. 2018. IL-1\u03b2 enables CNS access to CCR2(hi) monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells. Proc Natl Acad Sci U S A 115(6):E1194\u2013e203.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"2355_CR23","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1016\/j.neuron.2024.05.025","volume":"112","author":"T Garton","year":"2024","unstructured":"Garton, T., S. P. Gadani, A. J. Gill, and P. A. Calabresi. 2024. Neurodegeneration and demyelination in multiple sclerosis. Neuron 112(19):3231\u20133251.","journal-title":"Neuron"},{"issue":"2","key":"2355_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/bpa.12477","volume":"27","author":"W Barclay","year":"2017","unstructured":"Barclay, W., and M. L. Shinohara. 2017. Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Brain Pathology 27(2):213\u2013219.","journal-title":"Brain Pathology"},{"issue":"3","key":"2355_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/s12035-023-03618-y","volume":"61","author":"B Hou","year":"2024","unstructured":"Hou, B., J. Yin, S. Liu, J. Guo, B. Zhang, and Z. Zhang et al. 2024. Inhibiting the NLRP3 inflammasome with MCC950 alleviates neurological impairment in the brain of EAE mice. Molecular Neurobiology 61(3):1318\u20131330.","journal-title":"Molecular Neurobiology"},{"issue":"2","key":"2355_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/jnc.15650","volume":"163","author":"DA Galloway","year":"2022","unstructured":"Galloway, D. A., S. J. Carew, S. N. Blandford, R. Y. Benoit, N. J. Fudge, and T. Berry et al. 2022. Investigating the NLRP3 inflammasome and its regulator miR-223-3p in multiple sclerosis and experimental demyelination. Journal of Neurochemistry 163(2):94\u2013112.","journal-title":"Journal of Neurochemistry"},{"key":"2355_CR27","doi-asserted-by":"publisher","first-page":"116667","DOI":"10.1016\/j.bcp.2024.116667","volume":"232","author":"A Ot\u00e1lora-Alcaraz","year":"2025","unstructured":"Ot\u00e1lora-Alcaraz, A., T. Reilly, M. Or\u00f3-Nolla, M. C. Sun, L. Costelloe, and H. Kearney et al. 2025. The NLRP3 inflammasome: A central player in multiple sclerosis. Biochemical Pharmacology 232:116667.","journal-title":"Biochemical Pharmacology"},{"key":"2355_CR28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65469","author":"Y Chen","year":"2021","unstructured":"Chen, Y., R.B. Kunjamma, M. Weiner, J.R. Chan, and B. Popko. 2021. Prolonging the integrated stress response enhances CNS remyelination in an inflammatory environment. eLife. https:\/\/doi.org\/10.7554\/eLife.65469.","journal-title":"eLife"},{"key":"2355_CR29","doi-asserted-by":"crossref","unstructured":"O\u2019Loughlin, E., C. Madore, H. Lassmann, and O. Butovsky. 2018. Microglial phenotypes and functions in multiple sclerosis. Cold Spring Harb Perspect Med 8(2): a028993.","DOI":"10.1101\/cshperspect.a028993"},{"key":"2355_CR30","unstructured":"Kempuraj, D., R. Thangavel, P. A. Natteru, G. P. Selvakumar, D. Saeed, and H. Zahoor et al. 2016. Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine\u00a01(1): 1003."},{"key":"2355_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098447","author":"V Nociti","year":"2023","unstructured":"Nociti, V., and M. Romozzi. 2023. The role of BDNF in multiple sclerosis neuroinflammation. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms24098447.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"2355_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.molmed.2020.09.001","volume":"27","author":"F Provenzano","year":"2021","unstructured":"Provenzano, F., M.J. P\u00e9rez, and M. Deleidi. 2021. Redefining microglial identity in health and disease at single-cell resolution. Trends in Molecular Medicine 27 (1): 47\u201359.","journal-title":"Trends in Molecular Medicine"},{"key":"2355_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","volume":"79","author":"SA Wolf","year":"2017","unstructured":"Wolf, S.A., H.W. Boddeke, and H. Kettenmann. 2017. Microglia in physiology and disease. Annual Review of Physiology 79: 619\u201343.","journal-title":"Annual Review of Physiology"},{"key":"2355_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5753452","volume":"2021","author":"X Liu","year":"2021","unstructured":"Liu, X., J. Ma, G. Ding, Q. Gong, Y. Wang, H. Yu, et al. 2021. Microglia polarization from M1 toward M2 phenotype is promoted by Astragalus polysaccharides mediated through inhibition of miR-155 in experimental autoimmune encephalomyelitis. Oxidative Medicine and Cellular Longevity 2021: 5753452.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"2355_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-018-1261-y","volume":"15","author":"SU Vay","year":"2018","unstructured":"Vay, S.U., L.J. Flitsch, M. Rabenstein, R. Rogall, S. Blaschke, J. Kleinhaus, et al. 2018. The plasticity of primary microglia and their multifaceted effects on endogenous neural stem cells in vitro and in vivo. Journal of Neuroinflammation 15 (1): 226.","journal-title":"Journal of Neuroinflammation"},{"key":"2355_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233768","author":"D Nheu","year":"2022","unstructured":"Nheu, D., O. Ellen, S. Ye, E. Ozturk, M. Pagnin, S. Kertadjaja, et al. 2022. Modulation of the microglial Nogo-A\/NgR signaling pathway as a therapeutic target for multiple sclerosis. Cells. https:\/\/doi.org\/10.3390\/cells11233768.","journal-title":"Cells"},{"key":"2355_CR37","doi-asserted-by":"publisher","first-page":"108606","DOI":"10.1016\/j.pharmthera.2024.108606","volume":"255","author":"Y You","year":"2024","unstructured":"You, Y., Z. Chen, and W. W. Hu. 2024. The role of microglia heterogeneity in synaptic plasticity and brain disorders: Will sequencing shed light on the discovery of new therapeutic targets? Pharmacology & Therapeutics 255:108606.","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"2355_CR38","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12974-024-03296-0","volume":"21","author":"M Sadeghdoust","year":"2024","unstructured":"Sadeghdoust, M., A. Das, and D.K. Kaushik. 2024. Fueling neurodegeneration: Metabolic insights into microglia functions. Journal of Neuroinflammation 21 (1): 300.","journal-title":"Journal of Neuroinflammation"},{"issue":"6","key":"2355_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115777","volume":"44","author":"AM Lish","year":"2025","unstructured":"Lish, A.M., N. Ashour, R.V. Pearse, P.C. Galle, G.A. Orme, S.E. Heuer, et al. 2025. Astrocyte induction of disease-associated microglia is suppressed by acute exposure to fAD neurons in human iPSC triple cultures. Cell Reports 44 (6): 115777.","journal-title":"Cell Reports"},{"issue":"5","key":"2355_CR40","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.neuron.2020.02.008","volume":"105","author":"EC Damisah","year":"2020","unstructured":"Damisah, E. C., A. Rai, and J. Grutzendler. 2020. TREM2: Modulator of lipid metabolism in microglia. Neuron 105(5):759\u2013761.","journal-title":"Neuron"},{"key":"2355_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/biom13040692","author":"Z Qian","year":"2023","unstructured":"Qian, Z., J. Qin, Y. Lai, C. Zhang, and X. Zhang. 2023. Large-scale integration of single-cell RNA-Seq data reveals astrocyte diversity and transcriptomic modules across six central nervous system disorders. Biomolecules. https:\/\/doi.org\/10.3390\/biom13040692.","journal-title":"Biomolecules"},{"key":"2355_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11070896","author":"Y Li","year":"2021","unstructured":"Li, Y., W. Long, M. Gao, F. Jiao, Z. Chen, M. Liu, et al. 2021. TREM2 regulates high glucose-induced microglial inflammation via the NLRP3 signaling pathway. Brain Sciences. https:\/\/doi.org\/10.3390\/brainsci11070896.","journal-title":"Brain Sciences"},{"key":"2355_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168885","author":"E Harmon","year":"2022","unstructured":"Harmon, E., A. Doan, J. Bautista-Garrido, J.E. Jung, S.P. Marrelli, and G.S. Kim. 2022. Increased expression of interferon-induced transmembrane 3 (IFITM3) in stroke and other inflammatory conditions in the brain. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms23168885.","journal-title":"International Journal of Molecular Sciences"},{"key":"2355_CR44","doi-asserted-by":"publisher","first-page":"111501","DOI":"10.1016\/j.intimp.2024.111501","volume":"128","author":"R Sun","year":"2024","unstructured":"Sun, R., Y. F. Wang, and X. Yang. 2024. Knockdown of IFIT3 ameliorates multiple sclerosis via selectively regulating M1 polarization of microglia in an experimental autoimmune encephalomyelitis model. International Immunopharmacology 128:111501.","journal-title":"International Immunopharmacology"},{"issue":"1","key":"2355_CR45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12974-016-0536-4","volume":"13","author":"CY Chung","year":"2016","unstructured":"Chung, C.Y., and F. Liao. 2016. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells. Journal of Neuroinflammation 13 (1): 76.","journal-title":"Journal of Neuroinflammation"},{"issue":"8","key":"2355_CR46","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.2174\/1570159X19666211101142115","volume":"20","author":"LG Pereira","year":"2022","unstructured":"Pereira, L.G., P. Rodrigues, F.T. Viero, J.M. Frare, L.G. Ramanzini, and G. Trevisan. 2022. Interferon-beta injection in multiple sclerosis patients related to the induction of headache and flu-like pain symptoms: A systematic review and meta-analysis of randomised controlled trials. Current Neuropharmacology 20 (8): 1600\u20131612.","journal-title":"Current Neuropharmacology"},{"key":"2355_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cells10082139","author":"A Agasing","year":"2021","unstructured":"Agasing, A., J.L. Quinn, G. Kumar, and R.C. Axtell. 2021. Interferon-\u03b2 intensifies interleukin-23-driven pathogenicity of T helper cells in neuroinflammatory disease. Cells. https:\/\/doi.org\/10.3390\/cells10082139.","journal-title":"Cells"},{"key":"2355_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00543","volume":"7","author":"Y Sha","year":"2016","unstructured":"Sha, Y., and S. Markovic-Plese. 2016. Activated IL-1RI signaling pathway induces Th17 cell differentiation via interferon regulatory factor 4 signaling in patients with relapsing-remitting multiple sclerosis. Frontiers in Immunology 7: 543.","journal-title":"Frontiers in Immunology"},{"issue":"10","key":"2355_CR49","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00018-022-04547-0","volume":"79","author":"M Loix","year":"2022","unstructured":"Loix, M., E. Wouters, S. Vanherle, J. Dehairs, J. L. McManaman, and H. Kemps et al. 2022. Perilipin-2 limits remyelination by preventing lipid droplet degradation. Cellular and Molecular Life Sciences 79(10):515.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"7","key":"2355_CR50","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1093\/brain\/awaa158","volume":"143","author":"K J\u00e4ckle","year":"2020","unstructured":"J\u00e4ckle, K., T. Zeis, N. Schaeren-Wiemers, A. Junker, F. van der Meer, N. Kramann, et al. 2020. Molecular signature of slowly expanding lesions in progressive multiple sclerosis. Brain 143 (7): 2073\u201388.","journal-title":"Brain"},{"issue":"4","key":"2355_CR51","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.cmet.2020.03.015","volume":"31","author":"ES Jung","year":"2020","unstructured":"Jung, E.S., and I. Mook-Jung. 2020. New microglia on the block. Cell Metabolism 31 (4): 664\u20136.","journal-title":"Cell Metabolism"},{"issue":"4","key":"2355_CR52","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/glia.23505","volume":"67","author":"T Kreisel","year":"2019","unstructured":"Kreisel, T., B. Wolf, E. Keshet, and T. Licht. 2019. Unique role for dentate gyrus microglia in neuroblast survival and in VEGF-induced activation. Glia 67(4):594\u2013618.","journal-title":"Glia"},{"issue":"3","key":"2355_CR53","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/glia.24655","volume":"73","author":"SM Kooistra","year":"2025","unstructured":"Kooistra, S. M., and L. Schirmer. 2025. Multiple sclerosis: Glial cell diversity in time and space. Glia 73(3):574\u2013590.","journal-title":"Glia"},{"issue":"19","key":"2355_CR54","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky, D.J., G. Petroni, R.K. Amaravadi, E.H. Baehrecke, A. Ballabio, P. Boya, et al. 2021. Autophagy in major human diseases. EMBO Journal 40 (19): e108863.","journal-title":"EMBO Journal"},{"issue":"8","key":"2355_CR55","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.tibs.2021.01.006","volume":"46","author":"KE King","year":"2021","unstructured":"King, K. E., T. T. Losier, and R. C. Russell. 2021. Regulation of autophagy enzymes by nutrient signaling. Trends in Biochemical Sciences 46(8):687\u2013700.","journal-title":"Trends in Biochemical Sciences"},{"key":"2355_CR56","doi-asserted-by":"publisher","first-page":"13254","DOI":"10.1038\/ncomms13254","volume":"7","author":"P Dalle Pezze","year":"2016","unstructured":"Dalle Pezze, P., S. Ruf, A. G. Sonntag, M. Langelaar-Makkinje, P. Hall, and A. M. Heberle et al. 2016. A systems study reveals concurrent activation of AMPK and mTOR by amino acids. Nature Communications 7:13254.","journal-title":"Nature Communications"},{"issue":"5","key":"2355_CR57","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1007\/s10753-018-0835-2","volume":"41","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y., S. Huang, J. Liu, X. Wu, S. Zhou, and K. Dai et al. 2018. Mitophagy contributes to the pathogenesis of inflammatory diseases. Inflammation 41(5):1590\u20131600.","journal-title":"Inflammation"},{"issue":"2","key":"2355_CR58","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/15548627.2017.1362525","volume":"14","author":"T Riffelmacher","year":"2018","unstructured":"Riffelmacher, T., F. C. Richter, and A. K. Simon. 2018. Autophagy dictates metabolism and differentiation of inflammatory immune cells. Autophagy 14(2):199\u2013206.","journal-title":"Autophagy"},{"issue":"1","key":"2355_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02371-z","volume":"10","author":"Y Fu","year":"2025","unstructured":"Fu, Y., B. Wang, A. Alu, W. Hong, H. Lei, X. He, et al. 2025. Immunosenescence: Signaling pathways, diseases and therapeutic targets. Signal Transduction and Targeted Therapy 10 (1): 250.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"2","key":"2355_CR60","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/cei\/uxac017","volume":"209","author":"D Shen","year":"2022","unstructured":"Shen, D., K. Liu, H. Wang, and H. Wang. 2022. Autophagy modulation in multiple sclerosis and experimental autoimmune encephalomyelitis. Clinical and Experimental Immunology 209(2):140\u2013150.","journal-title":"Clinical and Experimental Immunology"},{"key":"2355_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fimmu.2017.00165","volume":"8","author":"CW Keller","year":"2017","unstructured":"Keller, C.W., and J.D. L\u00fcnemann. 2017. Autophagy and autophagy-related proteins in CNS autoimmunity. Frontiers in Immunology 8: 165.","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"2355_CR62","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson, K.V., M. Deng, and J.P. Ting. 2019. The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nature Reviews Immunology 19 (8): 477\u201389.","journal-title":"Nature Reviews Immunology"},{"issue":"2","key":"2355_CR63","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4049\/jimmunol.0901363","volume":"183","author":"FG Bauernfeind","year":"2009","unstructured":"Bauernfeind, F.G., G. Horvath, A. Stutz, E.S. Alnemri, K. MacDonald, D. Speert, et al. 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. Journal of Immunology (Baltimore, Md.\u202f: 1950) 183 (2): 787\u201391.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"issue":"18","key":"2355_CR64","doi-asserted-by":"publisher","first-page":"7554","DOI":"10.1074\/jbc.M116.773788","volume":"292","author":"NA de Weerd","year":"2017","unstructured":"de Weerd, N. A., A. Y. Matthews, P. R. Pattie, N. M. Bourke, S. S. Lim, and J. P. Vivian et al. 2017. A hot spot on interferon \u03b1\/\u03b2 receptor subunit 1 (IFNAR1) underpins its interaction with interferon-\u03b2 and dictates signaling. Journal of Biological Chemistry 292(18):7554\u20137565.","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"2355_CR65","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1080\/15548627.2020.1761653","volume":"17","author":"Y Wu","year":"2021","unstructured":"Wu, Y., S. Jin, Q. Liu, Y. Zhang, L. Ma, Z. Zhao, et al. 2021. Selective autophagy controls the stability of transcription factor IRF3 to balance type I interferon production and immune suppression. Autophagy 17 (6): 1379\u201392.","journal-title":"Autophagy"},{"issue":"8","key":"2355_CR66","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","volume":"55","author":"H Xian","year":"2022","unstructured":"Xian, H., K. Watari, E. Sanchez-Lopez, J. Offenberger, J. Onyuru, and H. Sampath et al. 2022. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity 55(8):1370\u201385e8.","journal-title":"Immunity"},{"issue":"5","key":"2355_CR67","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.cmet.2013.10.013","volume":"18","author":"LA O'Neill","year":"2013","unstructured":"O\u2019Neill, L.A. 2013. Cardiolipin and the Nlrp3 inflammasome. Cell Metabolism 18 (5): 610\u20132.","journal-title":"Cell Metabolism"},{"issue":"7293","key":"2355_CR68","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell, P., H. Kono, K. J. Rayner, C. M. Sirois, G. Vladimer, and F. G. Bauernfeind et al. 2010. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464(7293):1357\u20131361.","journal-title":"Nature"},{"issue":"1","key":"2355_CR69","doi-asserted-by":"publisher","first-page":"8396","DOI":"10.1038\/s41467-023-44203-0","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., L. Luo, X. Xu, J. Wu, F. Wang, and Y. Lu et al. 2023. Acetylation is required for full activation of the NLRP3 inflammasome. Nature Communications 14(1):8396.","journal-title":"Nature Communications"},{"issue":"1","key":"2355_CR70","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s41467-024-45396-8","volume":"15","author":"X Yu","year":"2024","unstructured":"Yu, X., R. E. Matico, R. Miller, D. Chauhan, B. Van Schoubroeck, and K. Grauwen et al. 2024. Structural basis for the oligomerization-facilitated NLRP3 activation. Nature Communications 15(1):1164.","journal-title":"Nature Communications"},{"issue":"4","key":"2355_CR71","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1021\/acschemneuro.0c00519","volume":"12","author":"M Riaz","year":"2021","unstructured":"Riaz, M., A.U. Rehman, S.A. Shah, H. Rafiq, S. Lu, Y. Qiu, et al. 2021. Predicting multi-interfacial binding mechanisms of NLRP3 and ASC pyrin domains in inflammasome activation. ACS Chemical Neuroscience 12 (4): 603\u2013612.","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"2355_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00650-z","volume":"6","author":"Y Li","year":"2021","unstructured":"Li, Y., H. Huang, B. Liu, Y. Zhang, X. Pan, X.Y. Yu, et al. 2021. Inflammasomes as therapeutic targets in human diseases. Signal Transduction and Targeted Therapy 6 (1): 247.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"26","key":"2355_CR73","first-page":"E6065","volume":"115","author":"BA McKenzie","year":"2018","unstructured":"McKenzie, B.A., M.K. Mamik, L.B. Saito, R. Boghozian, M.C. Monaco, E.O. Major, et al. 2018. Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 115 (26): E6065-e74.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"16","key":"2355_CR74","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.15252\/embj.201694696","volume":"35","author":"L Sborgi","year":"2016","unstructured":"Sborgi, L., S. R\u00fchl, E. Mulvihill, J. Pipercevic, R. Heilig, H. Stahlberg, et al. 2016. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. The EMBO Journal 35 (16): 1766\u201378.","journal-title":"The EMBO Journal"},{"issue":"Pt 10","key":"2355_CR75","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1107\/S2053230X25007149","volume":"81","author":"L De Colibus","year":"2025","unstructured":"De Colibus, L., P. Ludzia, A. Biasutto, A. Pica, J. T. S. Hopper, and A. Jazayeri et al. 2025. Improved structure of mouse gasdermin D: A new blueprint for structure-based drug design. Acta Crystallogr F Struct Biol Commun 81(Pt 10):408\u2013415.","journal-title":"Acta Crystallogr F Struct Biol Commun"},{"key":"2355_CR76","volume":"2022","author":"X Li","year":"2022","unstructured":"Li, X., P. Zhang, Z. Yin, F. Xu, Z.H. Yang, J. Jin, et al. 2022. Caspase-1 and gasdermin D afford the optimal targets with distinct switching strategies in NLRP1b inflammasome-induced cell death. Research (Washington, D.C.) 2022: 9838341.","journal-title":"Research (Washington, D.C.)"},{"issue":"7","key":"2355_CR77","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.devcel.2025.02.005","volume":"60","author":"N Zhang","year":"2025","unstructured":"Zhang, N., and D. Xu. 2025. Controlling pyroptosis through post-translational modifications of gasdermin D. Developmental Cell 60(7):994\u20131007.","journal-title":"Developmental Cell"},{"issue":"5","key":"2355_CR78","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/brain\/awaa084","volume":"143","author":"S Malhotra","year":"2020","unstructured":"Malhotra, S., C. Costa, H. Eixarch, C. W. Keller, L. Amman, and H. Mart\u00ednez-Banaclocha et al. 2020. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients. Brain 143(5):1414\u20131430.","journal-title":"Brain"},{"key":"2355_CR79","doi-asserted-by":"publisher","first-page":"107880","DOI":"10.1016\/j.pharmthera.2021.107880","volume":"227","author":"S Shao","year":"2021","unstructured":"Shao, S., C. Chen, G. Shi, Y. Zhou, Y. Wei, and N. Fan et al. 2021. Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis. Pharmacology & Therapeutics 227:107880.","journal-title":"Pharmacology & Therapeutics"},{"key":"2355_CR80","doi-asserted-by":"publisher","first-page":"128483","DOI":"10.1016\/j.jhazmat.2022.128483","volume":"430","author":"H Tang","year":"2022","unstructured":"Tang, H., H. Huang, D. Wang, P. Li, Z. Tian, and D. Li et al. 2022. TFEB ameliorates autophagy flux disturbance induced by PBDE-47 via up-regulating autophagy-lysosome fusion. Journal of Hazardous Materials 430:128483.","journal-title":"Journal of Hazardous Materials"},{"key":"2355_CR81","doi-asserted-by":"publisher","first-page":"591803","DOI":"10.3389\/fimmu.2020.591803","volume":"11","author":"M Biasizzo","year":"2020","unstructured":"Biasizzo, M., and N. Kopitar-Jerala. 2020. Interplay between NLRP3 inflammasome and autophagy. Frontiers in Immunology 11:591803.","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"2355_CR82","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41418-023-01195-0","volume":"30","author":"E Van San","year":"2023","unstructured":"Van San, E., A.C. Debruyne, G. Veeckmans, Y.Y. Tyurina, V.A. Tyurin, H. Zheng, et al. 2023. Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression. Cell Death and Differentiation 30 (9): 2092\u20132103.","journal-title":"Cell Death and Differentiation"},{"issue":"6 Suppl","key":"2355_CR83","first-page":"s159","volume":"22","author":"FM Hart","year":"2016","unstructured":"Hart, F.M., and J. Bainbridge. 2016. Current and emerging treatment of multiple sclerosis. American Journal of Managed Care 22 (6 Suppl): s159-70.","journal-title":"American Journal of Managed Care"},{"issue":"4","key":"2355_CR84","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1002\/jcb.27792","volume":"120","author":"L Xu","year":"2019","unstructured":"Xu, L., C. Zhang, N. Jiang, D. He, Y. Bai, and Y. Xin. 2019. Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis. Journal of Cellular Biochemistry 120(4):5160\u20135168.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"8","key":"2355_CR85","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70455","volume":"29","author":"S Patergnani","year":"2025","unstructured":"Patergnani, S., M. Laudisi, M. Bonora, G. Righes, S. Straudi, M.R. Wieckowski, et al. 2025. Pathogenetic involvement of autophagy and mitophagy in primary progressive multiple sclerosis. Journal of Cellular and Molecular Medicine 29 (8): e70455.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"2355_CR86","doi-asserted-by":"publisher","first-page":"603710","DOI":"10.3389\/fncel.2020.603710","volume":"14","author":"C Misrielal","year":"2020","unstructured":"Misrielal, C., M. Mauthe, F. Reggiori, and B. J. L. Eggen. 2020. Autophagy in multiple sclerosis: Two sides of the same coin. Frontiers in Cellular Neuroscience 14:603710.","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"7","key":"2355_CR87","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s10571-021-01111-5","volume":"42","author":"R Asgari","year":"2022","unstructured":"Asgari, R., R. Yarani, P. Mohammadi, and M. S. Emami Aleagha. 2022. HIF-1\u03b1 in the crosstalk between reactive oxygen species and autophagy process: A review in multiple sclerosis. Cellular and Molecular Neurobiology 42(7):2121\u20132129.","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"4","key":"2355_CR88","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae209","volume":"6","author":"IL Tan","year":"2024","unstructured":"Tan, I.L., R. Modderman, A. Stachurska, R. Almeida, R. de Vries, D.J. Heersema, et al. 2024. Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencing. Brain Communications 6 (4): fcae209.","journal-title":"Brain Communications"},{"key":"2355_CR89","doi-asserted-by":"publisher","first-page":"116673","DOI":"10.1016\/j.biopha.2024.116673","volume":"175","author":"A Shadab","year":"2024","unstructured":"Shadab, A., M. Abbasi-Kolli, M. Saharkhiz, S. H. Ahadi, B. Shokouhi, and J. S. Nahand. 2024. The interplay between mitochondrial dysfunction and NLRP3 inflammasome in multiple sclerosis: Therapeutic implications and animal model studies. Biomedicine & Pharmacotherapy 175:116673.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"19","key":"2355_CR90","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.2174\/0929867324666170316114452","volume":"24","author":"E Fetisova","year":"2017","unstructured":"Fetisova, E., B. Chernyak, G. Korshunova, M. Muntyan, and V. Skulachev. 2017. Mitochondria-targeted antioxidants as a prospective therapeutic strategy for multiple sclerosis. Current Medicinal Chemistry 24(19):2086\u20132114.","journal-title":"Current Medicinal Chemistry"},{"issue":"7","key":"2355_CR91","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41583-024-00823-z","volume":"25","author":"MS Woo","year":"2024","unstructured":"Woo, M.S., J.B. Engler, and M.A. Friese. 2024. The neuropathobiology of multiple sclerosis. Nature Reviews Neuroscience 25 (7): 493\u2013513.","journal-title":"Nature Reviews Neuroscience"},{"issue":"8","key":"2355_CR92","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1038\/s41418-021-00766-3","volume":"28","author":"A Di Rita","year":"2021","unstructured":"Di Rita, A., D. F. Angelini, T. Maiorino, V. Caputo, R. Cascella, and M. Kumar et al. 2021. Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy. Cell Death and Differentiation 28(8):2499\u20132516.","journal-title":"Cell Death and Differentiation"},{"issue":"6","key":"2355_CR93","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1080\/15548627.2021.1924969","volume":"17","author":"A Di Rita","year":"2021","unstructured":"Di Rita, A., and F. Strappazzon. 2021. A protective variant of the autophagy receptor CALCOCO2\/NDP52 in multiple sclerosis (MS). Autophagy 17 (6): 1565\u20137.","journal-title":"Autophagy"},{"issue":"12","key":"2355_CR94","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41419-018-1227-0","volume":"9","author":"B Zhitomirsky","year":"2018","unstructured":"Zhitomirsky, B., A. Yunaev, R. Kreiserman, A. Kaplan, M. Stark, and Y.G. Assaraf. 2018. Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity. Cell Death and Disease 9 (12): 1191.","journal-title":"Cell Death and Disease"},{"key":"2355_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158077","author":"AG Vakrakou","year":"2022","unstructured":"Vakrakou, A.G., A. Alexaki, M.E. Brinia, M. Anagnostouli, L. Stefanis, and P. Stathopoulos. 2022. The mTOR signaling pathway in multiple sclerosis; From animal models to human data. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms23158077.","journal-title":"International Journal of Molecular Sciences"},{"issue":"13","key":"2355_CR96","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1242\/jcs.146365","volume":"129","author":"G Napolitano","year":"2016","unstructured":"Napolitano, G., and A. Ballabio. 2016. TFEB at a glance. Journal of Cell Science 129(13):2475\u20132481.","journal-title":"Journal of Cell Science"},{"issue":"1","key":"2355_CR97","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12031-021-01894-8","volume":"72","author":"HQ Wang","year":"2022","unstructured":"Wang, H. Q., K. Y. Song, J. Z. Feng, S. Y. Huang, X. M. Guo, and L. Zhang et al. 2022. Caffeine inhibits activation of the NLRP3 inflammasome via autophagy to attenuate Microglia-Mediated neuroinflammation in experimental autoimmune encephalomyelitis. Journal of Molecular Neuroscience 72(1):97\u2013112.","journal-title":"Journal of Molecular Neuroscience"},{"key":"2355_CR98","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abb5077","author":"R Berglund","year":"2020","unstructured":"Berglund, R., A.O. Guerreiro-Cacais, M.Z. Adzemovic, M. Zeitelhofer, H. Lund, E. Ewing, et al. 2020. Microglial autophagy-associated phagocytosis is essential for recovery from neuroinflammation. Science Immunology. https:\/\/doi.org\/10.1126\/sciimmunol.abb5077.","journal-title":"Science Immunology"},{"issue":"4","key":"2355_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103741","volume":"24","author":"G Bj\u00f8rklund","year":"2025","unstructured":"Bj\u00f8rklund, G., D.R. Wallace, T. Hangan, M. Butnariu, L. Gurgas, and M. Peana. 2025. Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications. Autoimmunity Reviews 24 (4): 103741.","journal-title":"Autoimmunity Reviews"},{"key":"2355_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/neurosci6010023","author":"S Delic","year":"2025","unstructured":"Delic, S., S. Miletic Drakulic, M. Stepovic, J. Milosavljevic, M. Kovacevic Dimitrijevic, K. Jovanovic, et al. 2025. The connection between oxidative stress, mitochondrial dysfunction, iron metabolism and microglia in multiple sclerosis: A narrative review. NeuroSci. https:\/\/doi.org\/10.3390\/neurosci6010023.","journal-title":"NeuroSci"},{"issue":"1","key":"2355_CR101","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s40478-025-02020-0","volume":"13","author":"CJ Riedl","year":"2025","unstructured":"Riedl, C.J., D. Bormann, A. Steinmaurer, A. Novak, G. Testa, E. Poldlehner, et al. 2025. Inflammation alters myeloid cell and oligodendroglial iron-handling in multiple sclerosis. Acta Neuropathologica Communications 13 (1): 124.","journal-title":"Acta Neuropathologica Communications"},{"key":"2355_CR102","first-page":"606807","volume":"2011","author":"M Khalil","year":"2011","unstructured":"Khalil, M., C. Teunissen, and C. Langkammer. 2011. Iron and neurodegeneration in multiple sclerosis. Mult Scler Int 2011:606807.","journal-title":"Mult Scler Int"},{"issue":"1","key":"2355_CR103","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12974-019-1430-7","volume":"16","author":"YJ Yauger","year":"2019","unstructured":"Yauger, Y.J., S. Bermudez, K.E. Moritz, E. Glaser, B. Stoica, and K.R. Byrnes. 2019. Iron accentuated reactive oxygen species release by NADPH oxidase in activated microglia contributes to oxidative stress in vitro. Journal of Neuroinflammation 16 (1): 41.","journal-title":"Journal of Neuroinflammation"},{"issue":"1","key":"2355_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48087-3","volume":"9","author":"RS Khan","year":"2019","unstructured":"Khan, R.S., B. Baumann, K. Dine, Y. Song, J.L. Dunaief, S.F. Kim, et al. 2019. Dexras1 deletion and iron chelation promote neuroprotection in experimental optic neuritis. Scientific Reports 9 (1): 11664.","journal-title":"Scientific Reports"},{"key":"2355_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01560-4","author":"YJ Liu","year":"2025","unstructured":"Liu, Y.J., G.R. Jia, S.H. Zhang, Y.L. Guo, X.Z. Ma, H.M. Xu, et al. 2025. The role of microglia in neurodegenerative diseases: From the perspective of ferroptosis. Acta Pharmacologica Sinica. https:\/\/doi.org\/10.1038\/s41401-025-01560-4.","journal-title":"Acta Pharmacologica Sinica"},{"issue":"1","key":"2355_CR106","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/toxsci\/kfac115","volume":"191","author":"J Zhu","year":"2023","unstructured":"Zhu, J., F. Zhou, Q. Zhou, Y. Xu, Y. Li, and D. Huang et al. 2023. NLRP3 activation in microglia contributes to learning and memory impairment induced by chronic lead exposure in mice. Toxicological Sciences 191(1):179\u2013191.","journal-title":"Toxicological Sciences"},{"issue":"1","key":"2355_CR107","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/bab.1700","volume":"66","author":"T Sho","year":"2019","unstructured":"Sho, T., and J. Xu. 2019. Role and mechanism of ROS scavengers in alleviating NLRP3-mediated inflammation. Biotechnology and Applied Biochemistry 66 (1): 4\u201313.","journal-title":"Biotechnology and Applied Biochemistry"},{"key":"2355_CR108","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.chemosphere.2017.05.039","volume":"182","author":"A Fischbacher","year":"2017","unstructured":"Fischbacher, A., C. von Sonntag, and T. C. Schmidt. 2017. Hydroxyl radical yields in the Fenton process under various pH, ligand concentrations and hydrogen peroxide\/Fe(II) ratios. Chemosphere 182:738\u2013744.","journal-title":"Chemosphere"},{"issue":"4","key":"2355_CR109","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10534-017-0023-0","volume":"30","author":"H Huang","year":"2017","unstructured":"Huang, H., J. Chen, H. Lu, M. Zhou, Z. Chai, and Y. Hu. 2017. Iron-induced generation of mitochondrial ROS depends on AMPK activity. Biometals 30(4):623\u2013628.","journal-title":"Biometals"},{"key":"2355_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104934","volume":"78","author":"B Zierfuss","year":"2023","unstructured":"Zierfuss, B., Z. Wang, A.N. Jackson, D. Moezzi, and V.W. Yong. 2023. Iron in multiple sclerosis - Neuropathology, immunology, and real-world considerations. Multiple Sclerosis and Related Disorders 78: 104934.","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"1","key":"2355_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03016-8","volume":"21","author":"PF Wang","year":"2024","unstructured":"Wang, P.F., F. Jiang, Q.M. Zeng, W.F. Yin, Y.Z. Hu, Q. Li, et al. 2024. Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis. Journal of Neuroinflammation 21 (1): 28.","journal-title":"Journal of Neuroinflammation"},{"key":"2355_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612912","author":"E L\u00f3pez-Muguruza","year":"2023","unstructured":"L\u00f3pez-Muguruza, E., and C. Matute. 2023. Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms241612912.","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"2355_CR113","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41423-022-00883-0","volume":"19","author":"J Luoqian","year":"2022","unstructured":"Luoqian, J., W. Yang, X. Ding, Q.Z. Tuo, Z. Xiang, Z. Zheng, et al. 2022. Ferroptosis promotes T-cell activation-induced neurodegeneration in multiple sclerosis. Cellular and Molecular Immunology 19 (8): 913\u201324.","journal-title":"Cellular and Molecular Immunology"},{"key":"2355_CR114","doi-asserted-by":"publisher","first-page":"150651","DOI":"10.1016\/j.bbrc.2024.150651","volume":"735","author":"F Feng","year":"2024","unstructured":"Feng, F., X. Li, W. Wang, M. Dou, S. Li, and X. Jin et al. 2024. Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis. Biochemical and Biophysical Research Communications 735:150651.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"2355_CR115","doi-asserted-by":"publisher","first-page":"19630","DOI":"10.1038\/s41598-022-24152-2","volume":"12","author":"A Rayatpour","year":"2022","unstructured":"Rayatpour, A., F. Foolad, M. Heibatollahi, K. Khajeh, and M. Javan. 2022. Ferroptosis inhibition by deferiprone, attenuates myelin damage and promotes neuroprotection in demyelinated optic nerve. Scientific Reports 12 (1): 19630.","journal-title":"Scientific Reports"},{"key":"2355_CR116","doi-asserted-by":"publisher","first-page":"175909142211332","DOI":"10.1177\/17590914221133236","volume":"14","author":"S Liu","year":"2022","unstructured":"Liu, S., X. Gao, and S. Zhou. 2022. New target for prevention and treatment of neuroinflammation: Microglia iron accumulation and ferroptosis. ASN Neuro 14:17590914221133236.","journal-title":"ASN Neuro"},{"issue":"8006","key":"2355_CR117","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-024-07167-9","volume":"628","author":"L Peruzzotti-Jametti","year":"2024","unstructured":"Peruzzotti-Jametti, L., C.M. Willis, G. Krzak, R. Hamel, L. Pirvan, R.B. Ionescu, et al. 2024. Mitochondrial complex I activity in microglia sustains neuroinflammation. Nature 628 (8006): 195\u2013203.","journal-title":"Nature"},{"issue":"1","key":"2355_CR118","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1471-4159.2011.07536.x","volume":"120","author":"R Williams","year":"2012","unstructured":"Williams, R., C. L. Buchheit, N. E. Berman, and S. M. LeVine. 2012. Pathogenic implications of iron accumulation in multiple sclerosis. Journal of Neurochemistry 120(1):7\u201325.","journal-title":"Journal of Neurochemistry"},{"key":"2355_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103032","volume":"51","author":"CH Hawkes","year":"2021","unstructured":"Hawkes, C.H., M.D. Baker, D. Pohl, J. Lechner-Scott, M. Levy, and G. Giovannoni. 2021. Melatonin and multiple sclerosis. Multiple Sclerosis and Related Disorders 51: 103032.","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"2355_CR120","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3389\/fimmu.2018.00983","volume":"9","author":"F Piancone","year":"2018","unstructured":"Piancone, F., M. Saresella, I. Marventano, F. La Rosa, M. A. Santangelo, and D. Caputo et al. 2018. Monosodium urate crystals activate the inflammasome in primary progressive multiple sclerosis. Frontiers in Immunology 9:983.","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"2355_CR121","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41423-025-01284-9","volume":"22","author":"S Paik","year":"2025","unstructured":"Paik, S., J.K. Kim, H.J. Shin, E.J. Park, I.S. Kim, and E.K. Jo. 2025. Updated insights into the molecular networks for NLRP3 inflammasome activation. Cellular and Molecular Immunology 22 (6): 563\u201396.","journal-title":"Cellular and Molecular Immunology"},{"key":"2355_CR122","doi-asserted-by":"publisher","first-page":"894298","DOI":"10.3389\/fnmol.2022.894298","volume":"15","author":"Y Cui","year":"2022","unstructured":"Cui, Y., H. Yu, Z. Bu, L. Wen, L. Yan, and J. Feng. 2022. Focus on the role of the NLRP3 inflammasome in multiple sclerosis: Pathogenesis, diagnosis, and therapeutics. Frontiers in Molecular Neuroscience 15: 894298.","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"2355_CR123","doi-asserted-by":"publisher","unstructured":"Lan, T., D. Shang, L. Lin, H. Wang, J. Zou, and M. Hu et al. 2025. Mitochondrial NAD(+)-mediated mitophagy alleviates type I interferon response to the cytosolic mitochondrial DNA. Autophagy :1\u201319. Advance online publication. https:\/\/doi.org\/10.1080\/15548627.2025.2589909","DOI":"10.1080\/15548627.2025.2589909"},{"issue":"4 Suppl 98","key":"2355_CR124","first-page":"12","volume":"34","author":"Z Zhong","year":"2016","unstructured":"Zhong, Z., E. Sanchez-Lopez, and M. Karin. 2016. Autophagy, NLRP3 inflammasome and auto-inflammatory\/immune diseases. Clinical and Experimental Rheumatology 34 (4 Suppl 98): 12\u20136.","journal-title":"Clinical and Experimental Rheumatology"},{"key":"2355_CR125","doi-asserted-by":"publisher","unstructured":"Duran, G., J. Verreycken, Y. Dombrowski, M. Lamkanfi, P. Baeten, and B. Broux. 2025. Beyond the innate immune system: Rethinking inflammasomes in multiple sclerosis. Trends in Immunology.\u00a0S1471-4906(25)00271-6. Advance online publication. https:\/\/doi.org\/10.1016\/j.it.2025.10.014","DOI":"10.1016\/j.it.2025.10.014"},{"key":"2355_CR126","doi-asserted-by":"publisher","unstructured":"Guan, S., H. Zhu, M. Zhang, F. D. Shi, and B. Yan. 2025. Cell death in multiple sclerosis. Cell Death and Differentiation.\u00a0Advance online publication. https:\/\/doi.org\/10.1038\/s41418-025-01576-7","DOI":"10.1038\/s41418-025-01576-7"},{"key":"2355_CR127","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jneuroim.2018.03.001","volume":"319","author":"V Paunovic","year":"2018","unstructured":"Paunovic, V., I.V. Petrovic, M. Milenkovic, K. Janjetovic, V. Pravica, I. Dujmovic, et al. 2018. Autophagy-independent increase of ATG5 expression in T cells of multiple sclerosis patients. Journal of Neuroimmunology 319: 100\u20135.","journal-title":"Journal of Neuroimmunology"},{"key":"2355_CR128","doi-asserted-by":"publisher","first-page":"1572140","DOI":"10.3389\/fimmu.2025.1572140","volume":"16","author":"WG Zhang","year":"2025","unstructured":"Zhang, W.G., X.R. Zheng, Y. Yao, W.J. Sun, and B.Z. Shao. 2025. The role of NLRP3 inflammasome in multiple sclerosis: Pathogenesis and pharmacological application. Frontiers in Immunology 16: 1572140.","journal-title":"Frontiers in Immunology"},{"key":"2355_CR129","doi-asserted-by":"crossref","unstructured":"Liang P, Le W. 2015. Role of autophagy in the pathogenesis of multiple sclerosis. Neurosci Bull 31(4):435\u2013444.","DOI":"10.1007\/s12264-015-1545-5"},{"key":"2355_CR130","doi-asserted-by":"crossref","unstructured":"Peruzzotti-Jametti L, Pluchino S. Targeting Mitochondrial Metabolism inNeuroinflammation: Towards a Therapy for Progressive Multiple Sclerosis. TrendsMol Med\u00a02018;24(10):838\u2013855.","DOI":"10.1016\/j.molmed.2018.07.007"},{"key":"2355_CR131","doi-asserted-by":"crossref","unstructured":"Mandic M, Paunovic V, Vucicevic L, et al. 2024. No energy, no autophagy-Mechanisms andtherapeutic implications of autophagic response energy requirements. J Cell Physiol 239(11):e31366.","DOI":"10.1002\/jcp.31366"},{"key":"2355_CR132","doi-asserted-by":"crossref","unstructured":"Su KG, Banker G, Bourdette D, Forte M. 2009. Axonal degeneration in multiple sclerosis:the mitochondrial hypothesis. Curr Neurol Neurosci Rep 9(5):411\u2013417.","DOI":"10.1007\/s11910-009-0060-3"},{"key":"2355_CR133","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neuro.2023.09.008","volume":"99","author":"W Wang","year":"2023","unstructured":"Wang, W., R. Chang, Y. Wang, L. Hou, and Q. Wang. 2023. Mitophagy-dependent mitochondrial ROS mediates 2,5-hexanedione-induced NLRP3 inflammasome activation in BV2 microglia. Neurotoxicology 99:50\u201358.","journal-title":"Neurotoxicology"},{"issue":"5","key":"2355_CR134","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/emboj.2012.32","volume":"31","author":"C Settembre","year":"2012","unstructured":"Settembre, C., R. Zoncu, D. L. Medina, F. Vetrini, S. Erdin, and S. Erdin et al. 2012. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. Embo J 31(5):1095\u20131108.","journal-title":"Embo J"},{"key":"2355_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104209","volume":"68","author":"J Talbot","year":"2022","unstructured":"Talbot, J., H. H\u00f8jsgaard Chow, M. Mahler, S. Buhelt, R. Holm Hansen, H. Lundell, et al. 2022. Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis. Multiple Sclerosis and Related Disorders 68: 104209.","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"2355_CR136","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2023.07.032","volume":"208","author":"W Li","year":"2023","unstructured":"Li, W., M. Wu, Y. Li, and J. Shen. 2023. Reactive nitrogen species as therapeutic targets for autophagy\/mitophagy modulation to relieve neurodegeneration in multiple sclerosis: Potential application for drug discovery. Free Radical Biology and Medicine 208:37\u201351.","journal-title":"Free Radical Biology and Medicine"},{"key":"2355_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.103311","volume":"37","author":"V Pongratz","year":"2023","unstructured":"Pongratz, V., M. Bussas, P. Schmidt, S. Grahl, C. Gasperi, M. El Husseini, et al. 2023. Lesion location across diagnostic regions in multiple sclerosis. NeuroImage: Clinical 37: 103311.","journal-title":"NeuroImage: Clinical"},{"key":"2355_CR138","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.molimm.2019.10.027","volume":"117","author":"L Chen","year":"2020","unstructured":"Chen, L., X. Hou, M. Zhang, Y. Zheng, X. Zheng, Q. Yang, et al. 2020. MicroRNA-223-3p modulates dendritic cell function and ameliorates experimental autoimmune myocarditis by targeting the NLRP3 inflammasome. Molecular Immunology 117: 73\u201383.","journal-title":"Molecular Immunology"},{"key":"2355_CR139","doi-asserted-by":"publisher","first-page":"101202","DOI":"10.1016\/j.arr.2020.101202","volume":"65","author":"AG Wu","year":"2021","unstructured":"Wu, A. G., X. G. Zhou, G. Qiao, L. Yu, Y. Tang, and L. Yan et al. 2021. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases. Ageing Research Reviews 65:101202.","journal-title":"Ageing Research Reviews"},{"key":"2355_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106601","volume":"199","author":"C Agliardi","year":"2024","unstructured":"Agliardi, C., F.R. Guerini, M. Zanzottera, E. Bolognesi, D. Caputo, M. Rovaris, et al. 2024. Increased concentrations of P2X7R in oligodendrocyte derived extracellular vesicles of Multiple sclerosis patients. Neurobiology of Disease 199: 106601.","journal-title":"Neurobiology of Disease"},{"issue":"6756","key":"2355_CR141","doi-asserted-by":"publisher","first-page":"eadr1015","DOI":"10.1126\/science.adr1015","volume":"389","author":"J Wu","year":"2025","unstructured":"Wu, J., Y. Wang, X. Li, P. Ouyang, Y. Cai, and Y. He et al. 2025. Microglia replacement halts the progression of microgliopathy in mice and humans. Science 389(6756):eadr1015.","journal-title":"Science"},{"issue":"42","key":"2355_CR142","doi-asserted-by":"publisher","first-page":"eady4135","DOI":"10.1126\/sciadv.ady4135","volume":"11","author":"E Zhang","year":"2025","unstructured":"Zhang, E., H. Algarni, L. Zhang, C. J. Chao, S. He, and A. Upadhye et al. 2025. Nanoparticle-boosted myeloid-derived suppressor cell therapy for immune reprogramming in multiple sclerosis. Science Advances 11(42):eady4135.","journal-title":"Science Advances"},{"issue":"1","key":"2355_CR143","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.gene.2016.04.042","volume":"588","author":"M Igci","year":"2016","unstructured":"Igci, M., M. Baysan, R. Yigiter, M. Ulasli, S. Geyik, and R. Bayraktar et al. 2016. Gene expression profiles of autophagy-related genes in multiple sclerosis. Gene 588(1):38\u201346.","journal-title":"Gene"},{"issue":"2","key":"2355_CR144","first-page":"95","volume":"17","author":"X Feng","year":"2017","unstructured":"Feng, X., H. Hou, Y. Zou, and L. Guo. 2017. Defective autophagy is associated with neuronal injury in a mouse model of multiple sclerosis. Bosnian Journal of Basic Medical Sciences \/ Udru\u017eenje Basi\u010dnih Mediciniskih Znanosti = Association of Basic Medical Sciences 17(2):95\u2013103.","journal-title":"Bosnian Journal of Basic Medical Sciences \/ Udru\u017eenje Basi\u010dnih Mediciniskih Znanosti = Association of Basic Medical Sciences"},{"issue":"11","key":"2355_CR145","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/abbs\/gmz098","volume":"51","author":"Z Cao","year":"2019","unstructured":"Cao, Z., Y. Wang, Z. Long, and G. He. 2019. Interaction between autophagy and the NLRP3 inflammasome. Acta Biochimica et Biophysica Sinica (Shanghai) 51 (11): 1087\u20131095.","journal-title":"Acta Biochimica et Biophysica Sinica (Shanghai)"},{"issue":"1","key":"2355_CR146","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/imr.12908","volume":"297","author":"D Chauhan","year":"2020","unstructured":"Chauhan, D., L. Vande Walle, and M. Lamkanfi. 2020. Therapeutic modulation of inflammasome pathways. Immunological Reviews 297 (1): 123\u201338.","journal-title":"Immunological Reviews"},{"issue":"15","key":"2355_CR147","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.2174\/0109298673289984231127062528","volume":"31","author":"S Lou","year":"2024","unstructured":"Lou, S., M. Wu, and S. Cui. 2024. Targeting NLRP3 inflammasome: Structure, function, and inhibitors. Current Medicinal Chemistry 31 (15): 2021\u20132051.","journal-title":"Current Medicinal Chemistry"},{"issue":"9","key":"2355_CR148","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1177\/0269881120914206","volume":"34","author":"K Recourt","year":"2020","unstructured":"Recourt, K., J. van der Aart, G. Jacobs, M. de Kam, W. Drevets, L. van Nueten, et al. 2020. Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial. Journal of Psychopharmacology 34 (9): 1030\u201342.","journal-title":"Journal of Psychopharmacology"},{"key":"2355_CR149","doi-asserted-by":"publisher","first-page":"115435","DOI":"10.1016\/j.bcp.2023.115435","volume":"209","author":"TK Motawi","year":"2023","unstructured":"Motawi, T. K., S. A. El-Maraghy, A. S. Kamel, S. E. Said, and M. A. Kortam. 2023. Modulation of p38 MAPK and Nrf2\/HO-1\/NLRP3 inflammasome signaling and pyroptosis outline the anti-neuroinflammatory and remyelinating characters of clemastine in EAE rat model. Biochemical Pharmacology 209:115435.","journal-title":"Biochemical Pharmacology"},{"issue":"3","key":"2355_CR150","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41593-025-01875-9","volume":"28","author":"A Kadowaki","year":"2025","unstructured":"Kadowaki, A., M.A. Wheeler, Z. Li, B.M. Andersen, H.G. Lee, T. Illouz, et al. 2025. CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse model. Nature Neuroscience 28 (3): 470\u201386.","journal-title":"Nature Neuroscience"},{"key":"2355_CR151","doi-asserted-by":"crossref","unstructured":"Su, C., H. Liu, L. Liu, C. Bai, Q. Li, and L. Jiang et al. 2025. Ma Xing Shi Gan Decoction alleviates lipopolysaccharide-induced pneumonia by inhibiting NLRP3 inflammasome activation via AMPK\/mTOR\/ULK1-mediated autophagy. Journal of Ethnopharmacology ;353(Pt B):120418.","DOI":"10.1016\/j.jep.2025.120418"},{"issue":"1","key":"2355_CR152","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12883-024-03596-1","volume":"24","author":"JE Svensson","year":"2024","unstructured":"Svensson, J.E., M. Bolin, D. Thor, P.A. Williams, R. Brautaset, M. Carlsson, et al. 2024. Evaluating the effect of Rapamycin treatment in alzheimer\u2019s disease and aging using in vivo imaging: The ERAP phase IIa clinical study protocol. BMC Neurology 24 (1): 111.","journal-title":"BMC Neurology"},{"issue":"5","key":"2355_CR153","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41419-020-2565-2","volume":"11","author":"B Hou","year":"2020","unstructured":"Hou, B., Y. Zhang, P. Liang, Y. He, B. Peng, W. Liu, et al. 2020. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype. Cell Death & Disease 11 (5): 377.","journal-title":"Cell Death & Disease"},{"key":"2355_CR154","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3389\/fimmu.2019.02578","volume":"10","author":"A S\u00e1nchez-Fern\u00e1ndez","year":"2019","unstructured":"S\u00e1nchez-Fern\u00e1ndez, A., D.B. Skouras, C.A. Dinarello, and R. L\u00f3pez-Vales. 2019. OLT1177 (Dapansutrile), a selective NLRP3 inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis. Frontiers in Immunology 10: 2578.","journal-title":"Frontiers in Immunology"},{"key":"2355_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117747","volume":"253","author":"L Xu","year":"2020","unstructured":"Xu, L., C. Zhang, D. He, N. Jiang, Y. Bai, and Y. Xin. 2020. Rapamycin and MCC950 modified gut microbiota in experimental autoimmune encephalomyelitis mouse by brain gut axis. Life Sciences 253: 117747.","journal-title":"Life Sciences"},{"key":"2355_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103227","volume":"64","author":"PX Shen","year":"2021","unstructured":"Shen, P.X., X. Li, S.Y. Deng, L. Zhao, Y.Y. Zhang, X. Deng, et al. 2021. Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor. EBioMedicine 64: 103227.","journal-title":"EBioMedicine"},{"key":"2355_CR157","doi-asserted-by":"publisher","first-page":"581691","DOI":"10.3389\/fphar.2020.581691","volume":"11","author":"Q Li","year":"2020","unstructured":"Li, Q., C. Bai, R. Yang, W. Xing, X. Pang, S. Wu, et al. 2020. Deciphering the pharmacological mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through integrating network pharmacology and experimental exploration. Frontiers in Pharmacology 11: 581691.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"2355_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00904-9","volume":"5","author":"MM Gonzales","year":"2025","unstructured":"Gonzales, M.M., V.R. Garbarino, T.F. Kautz, X. Song, M. Lopez-Cruzan, L. Linehan, et al. 2025. Rapamycin treatment for Alzheimer\u2019s disease and related dementias: A pilot phase 1 clinical trial. Communications Medicine (London) 5 (1): 189.","journal-title":"Communications Medicine (London)"},{"issue":"1","key":"2355_CR159","doi-asserted-by":"publisher","first-page":"8126","DOI":"10.1038\/s41467-025-63279-4","volume":"16","author":"NL Kazakou","year":"2025","unstructured":"Kazakou, N. L., N. Bestard-Cuche, L. J. Wagstaff, K. Horan, L. Seeker, and S. B\u00f8strand et al. 2025. Metformin alters mitochondria-related metabolism and enhances human oligodendrocyte function. Nature Communications 16(1):8126.","journal-title":"Nature Communications"},{"issue":"1","key":"2355_CR160","doi-asserted-by":"publisher","DOI":"10.1002\/pdi3.66","volume":"3","author":"X Li","year":"2025","unstructured":"Li, X., M. Chen, B. Xu, Y. Fan, C. Dai, and Z. Dong. 2025. VX-765 alleviates motor and cognitive impairments via inhibiting PANoptosis activation in the neonatal rats after hypoxic-ischemic brain damage. Pediatric Discovery 3 (1): e66.","journal-title":"Pediatric Discovery"},{"issue":"1","key":"2355_CR161","doi-asserted-by":"publisher","first-page":"15089","DOI":"10.1038\/s41598-017-15352-2","volume":"7","author":"F Gatto","year":"2017","unstructured":"Gatto, F., B. Rossi, A. Tarallo, E. Polishchuk, R. Polishchuk, and A. Carrella et al. 2017. AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe disease. Scientific Reports 7(1):15089.","journal-title":"Scientific Reports"},{"issue":"7","key":"2355_CR162","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.chembiol.2025.06.005","volume":"32","author":"A Sylvain","year":"2025","unstructured":"Sylvain, A., N. Stoehr, F. Ma, A. Cernijenko, M. Schr\u00f6der, and M. Khoshouei et al. 2025. A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner. Cell Chem Biol 32(7):955\u201368e13.","journal-title":"Cell Chem Biol"},{"issue":"7","key":"2355_CR163","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu, J.J., X. Liu, S. Xia, Z. Zhang, Y. Zhang, J. Zhao, et al. 2020. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nature Immunology 21 (7): 736\u201345.","journal-title":"Nature Immunology"},{"key":"2355_CR164","doi-asserted-by":"crossref","unstructured":"Li J, Lai M, Zhang X, et al. 2022. PINK1-parkinmediated neuronal mitophagy deficiency in prion disease. Cell Death Dis 13(2):162.","DOI":"10.1038\/s41419-022-04613-2"},{"issue":"9","key":"2355_CR165","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.chembiol.2025.08.006","volume":"32","author":"W Kim","year":"2025","unstructured":"Kim, W., S. Kim, H. Woo, R. A. Jojare, R. Mall, and A. Nicotra et al. 2025. A potent NLRP3 inhibitor effective against both MCC950-sensitive and -resistant inflammation. Cell Chem Biol 32(9):1125\u201339e7.","journal-title":"Cell Chem Biol"},{"issue":"2","key":"2355_CR166","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.27270","volume":"98","author":"JJ Sabatino","year":"2025","unstructured":"Sabatino, J.J., B.A.C. Cree, and S.L. Hauser. 2025. New horizons for Multiple Sclerosis therapy: 2025 and beyond. Annals of Neurology 98 (2): 317\u201328.","journal-title":"Annals of Neurology"},{"key":"2355_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/nano6050087","author":"A Polchi","year":"2016","unstructured":"Polchi, A., A. Magini, J. Mazuryk, B. Tancini, J. Gapi\u0144ski, A. Patkowski, et al. 2016. Rapamycin loaded solid lipid nanoparticles as a new tool to deliver mTOR inhibitors: Formulation and in vitro characterization. Nanomaterials (Basel). https:\/\/doi.org\/10.3390\/nano6050087.","journal-title":"Nanomaterials (Basel)"},{"key":"2355_CR168","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111614","author":"AB Raneros","year":"2021","unstructured":"Raneros, A.B., C.R. Bernet, A.B. Fl\u00f3rez, and B. Suarez-Alvarez. 2021. An epigenetic insight into NLRP3 inflammasome activation in inflammation-related processes. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9111614.","journal-title":"Biomedicines"},{"issue":"1","key":"2355_CR169","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13072-025-00567-9","volume":"18","author":"H Liu","year":"2025","unstructured":"Liu, H., H. Zhang, Z. Yin, and M. Hou. 2025. Assessment of relationships between epigenetic age acceleration and multiple sclerosis: A bidirectional Mendelian randomization study. Epigenetics & Chromatin 18 (1): 7.","journal-title":"Epigenetics & Chromatin"},{"issue":"9","key":"2355_CR170","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s12276-024-01298-9","volume":"56","author":"L Luo","year":"2024","unstructured":"Luo, L., F. Wang, X. Xu, M. Ma, G. Kuang, Y. Zhang, et al. 2024. STAT3 promotes NLRP3 inflammasome activation by mediating NLRP3 mitochondrial translocation. Experimental & Molecular Medicine 56 (9): 1980\u201390.","journal-title":"Experimental & Molecular Medicine"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02355-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02355-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T20:02:53Z","timestamp":1769198573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02355-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":170,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2355"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02355-9","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}